The United States Food and Drug Administration has granted approval for Waskyra, marking a significant milestone as the first gene therapy authorised for the treatment of Wiskott-Aldrich syndrome. The therapy,
The United States Food and Drug Administration has granted approval for Waskyra, marking a significant milestone as the first gene therapy authorised for the treatment of Wiskott-Aldrich syndrome. The therapy,






